Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis

BACKGROUND: Gastric cancer (GC) is a major malignancy worldwide, and its incidence and mortality rate are increasing year by year. Clinical guidelines mainly use palliative drug combination therapy for stage IV gastric cancer. In accordance with some small sample studies, surgery can prolong surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jianhui, Nan, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640680/
https://www.ncbi.nlm.nih.gov/pubmed/36386506
http://dx.doi.org/10.3389/fsurg.2022.927030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640680/
https://www.ncbi.nlm.nih.gov/pubmed/36386506
http://dx.doi.org/10.3389/fsurg.2022.927030

Ejemplares similares